RankingsPricing
  1. US-listed companies
  2. LIGAND PHARMACEUTICALS INC
  3. Financials
  4. FCF margin (%)

LIGAND PHARMACEUTICALS INC【LGND】

Market cap
$4B
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 202457+62.45%
Dec 31, 202335.1-42.61%
Dec 31, 202261.1+141.81%
Dec 31, 202125.3-6.02%
Dec 31, 202026.9-201.43%
Dec 31, 2019-26.5-134.51%
Dec 31, 201876.8+18.58%
Dec 31, 201764.8+15.45%
Dec 31, 201656.1-3.07%
Dec 31, 201557.9+81.73%
Dec 31, 201431.9-25.55%
Dec 31, 201342.8+2782.10%
Dec 31, 20121.5-135.68%
Dec 31, 2011-4.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)